Search News Archives
Special Offers and Promotions
Conferences | Events
Waters UNIFI Mass Spectrometry Data Acquisition Technology Now Compatible with Mass-MetaSite and WebMetabase
has announced new capabilities that provide greater data visibility and faster throughput analysis of metabolites during drug discovery.
By integrating UNIFI™ acquired data from the Vion IMS QTof™ or Xevo™G2 XS mass spectrometers with Molecular Discovery’s Mass-MetaSite and WebMetabase processing software, drug metabolism and pharmacokinetics (DMPK) scientists now have new analysis capabilities across a variety of molecules.
Waters UNIFI Scientific Information System is the first software platform to merge LC and high performance MS data (both quadrupole and time-of-flight) into a single solution that encompasses data acquisition, processing, visualization, reporting, and configurable compliance tools within a networked laboratory environment. This is the first time that the UNIFI Application Programming Interface (API) has been made accessible to an outside party and signals a larger Waters initiative to open its
“Waters helps our customers accelerate drug discovery and development to bring life-changing therapeutics to market. Coupling the superiority of our high resolution, ion mobility spectral data acquisition capabilities with the industry’s leading drug discovery metabolite identification software allows us to deliver new capabilities for DMPK scientists,” said
Mass-MetaSite features automatic peak detection, structure elucidation, and batch processing – attributes important for high throughput identification of known and unknown compounds, including those with complex structures such as cyclic peptides. WebMetabase accommodates a number of ADME dedicated workflows, such as soft spot analysis, glutathione reactive metabolite trapping, cytochrome reaction phenotyping, and species comparison. This integrates processed metabolite ID information into the broader context of DMPK and the discovery design-make-test cycle.
"The collaboration with Waters’ scientists and developers has opened up a great opportunity for our clients to have direct access to data acquired in